PSTI Financial Facts

Revenues: 0
Research and development expenses, net: -5M
See Full Income Statement

Total liabilities and stockholders' equity: 40.21M
Accumulated deficit: -168.08M
See Full Balance Sheet

Pluristem Therapeutics Inc. (PSTI) Earnings

  |   Expand Research on PSTI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
9/12/22 Q222 N/A-$0.02 N/A N/AN/A N/A N/A N/A